PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Major European mouse study reveals the role of genes in disease

2015-07-28
(Press-News.org) Since mice share 90 percent of our genes they play an important role in understanding human genetics. The European Mouse Disease Clinic (EUMODIC) brought together scientists from across Europe to investigate the functions of 320 genes in mice. Over half of these genes had no previously known role, and the remaining genes were poorly understood.

In order to study gene function, the EUMODIC consortium produced mouse lines which each had a single gene removed. These mouse lines were then analyzed in mouse clinics, where each line was assessed by a series of tests and investigations, allowing to establish the role of the missing genes. Over 80 percent of the mouse lines assessed had a characteristic that provided a clue to what the missing gene's role might be. If the mouse fails a hearing test, for example, it suggests the missing gene has a role in hearing. In total, they carried out over 150 different tests on each mouse line.

EUMODIC was the first step towards the creation of a database of all mouse gene functions, a vision now being realized by the International Mouse Phenotyping* Consortium (IMPC). The IMPC incorporates 20 centers from across the globe with the aim over the next ten years of uncovering the role of all 20,000 genes in the mouse genome. IMPC builds on the groundwork and achievements of EUMODIC in establishing the procedures and processes to identify and catalogue the function of genes.

First author Professor Martin Hrabe de Angelis, Director of Institute of Experimental Genetics at the Helmholtz Zentrum München, who invented the mouse clinic concept, said: "Our findings with regard to the genes examined are now available to the scientific community as a valid data set, which can be downloaded free of charge from the IMPC (International Mouse Phenotyping Consortium) website, and form an excellent basis on which we and other research groups can develop and test new hypotheses." This was the first time such a project has been attempted on this scale with multiple centers cooperating together from different countries. The consortium had to establish new standardized procedures to generate and assess the mouse lines and a central European database to store all the data.

All the findings from the project have been made publically available, allowing other scientists to use it in their own research. This will allow to understand more about genes we currently know very little about, and open up new avenues for research into the genetics of human disease.

INFORMATION:

Further information

Background: * A "phenotype" is the composite of an organism's observable characteristics. It includes not only morphological traits but also physiological properties and behavioral characteristics.

Original publication: Hrabe de Angelis, M. et al. (2015). Deciphering mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics, Nature Genetics, DOI: 10.1038/ng.3360

Link to the publication: http://www.nature.com/ng/journal/vaop/ncurrent/full/ng.3360.html

As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum Muenchen has about 2,300 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members.

The research objective of the Institute of Experimental Genetics (IEG) is to elucidate the causes and pathogenesis of human diseases. Due to its prominent role in interdisciplinary and international consortia, the IEG is a global leader in the systemic study of mouse models for human diseases and the elucidation of involved genes. The main focus is on metabolic diseases such as diabetes. The IEG is part of the Helmholtz Diabetes Center (HDC).

Rising life expectancy is causing an increase in age-related, but also sociological and environmental, influences on the genes. The Institute of Developmental Genetics (IDG) examines these changes in genetic material. In the Mouse Genetics group, genetic animal models are developed to investigate various diseases. These models are analyzed in the Disease Modelling research group in order to identify gene functions and cell processes and evaluate the influence of the environment and aging processes. The group focuses on the examination of neurological and psychiatric diseases.

The Institute of Pathology contributes to the identification and characterization of molecular mechanisms and pathways, which are relevant for disease development and progression. We endeavor to understand the interplay between environment and genetic, and to identify novel targets for therapeutic intervention.

The Comprehensive Pneumology Center (CPC) is a joint research project of the Helmholtz Zentrum München, the Ludwig-Maximilians-Universität Clinic Complex and the Asklepios Fachkliniken Muenchen-Gauting. The CPC's objective is to conduct research on chronic lung diseases in order to develop new diagnosis and therapy strategies. The CPC maintains a focus on experimental pneumology with the investigation of cellular, molecular and immunological mechanisms involved in lung diseases. The CPC is a site of the Deutsches Zentrum für Lungenforschung (DZL).

Contact for the media: Department of Communication, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg - Phone: +49 89 3187 2238 - Fax: +49 89 3187 3324 - E-mail: presse@helmholtz-muenchen.de

Scientific contact at Helmholtz Zentrum München: Prof. Dr. Martin Hrabe de Angelis, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Institute of Experimental Genetics, Ingolstädter Landstr. 1, 85764 Neuherberg - Phone: +49 89 3187 3502 - E-mail: hrabe@helmholtz-muenchen.de



ELSE PRESS RELEASES FROM THIS DATE:

Fatty acid increases performance of cellular powerhouse

2015-07-28
Mitochondria are essential to all higher forms of life. Every animal and plant depends on these small intracellular structures. Mitochondria have multiple tasks: Since they generate most of the cell's biochemical energy, they are referred to as the powerhouses of the cell. In addition, they are responsible for producing and breaking down amino acids and fats. They also regulate cellular death, called apoptosis. As a result, the spectrum of diseases that are linked to mitochondrial defects is wide, ranging from severe muscular and nervous disorders to neurodegenerative ...

Identifying ever-growing disturbances leading to freak waves

2015-07-28
Physicists like to study unusual kinds of waves, like freak waves found in the sea. Such wave movements can be studied using models designed to describe the dynamics of disturbances. Theoretical physicists, based in France have focused on finding ways of best explaining how wave disturbance occurs under very specific initial conditions that are key to the genesis of these disturbances. They looked for solutions to this puzzle by resolving a type of equation, called the nonlinear Schrödinger equation. It is solved by applying a method designed for studying instabilities ...

New drug for blood cancers now in five phase II clinical trials

2015-07-28
Researchers at University of California, San Diego School of Medicine have established the safety and dosing of a new drug for treating blood cancers. The findings are published online July 27 in The Lancet Haematology. The drug is a small molecule inhibitor that suppresses the activity of a signaling pathway believed to contribute to a variety of blood cancers' eventual resistance to standard chemotherapy treatments. More specifically, preclinical research, funded in part by the California Institute for Regenerative Medicine (CIRM), has shown that the drug coaxes ...

Researchers create promising new mouse model for lung injury repair

2015-07-28
Researchers at Children's Hospital Los Angeles and The Saban Research Institute of CHLA have created a dynamic functional mouse model for lung injury repair, a tool that will help scientists explain the origins of lung disease and provide a system by which new therapies can be identified and tested. Their findings have been published online by the American Journal of Respiratory Cell and Molecular Biology. The novel model used targeted Type 2 Alveolar Epithelial cells (AEC2), which line the small sac-like cavities of the lung and are thought to be responsible for injury ...

Report documents unmet need for expanded family planning services at CHCs

2015-07-28
WASHINGTON, DC (July 28, 2015)-- As part of a unique survey of nearly 2,000 women of childbearing age who receive health care at the nation's community health centers, 90 percent reported that they were not actively seeking to become pregnant in the next 12 months. Yet more than 3 out of 10 were not using contraceptives at the time of the survey.The survey's findings signal a clear unmet need for more comprehensive family planning services at health centers, according to a report issued today by the Geiger Gibson /RCHN Community Health Foundation Research Collaborative ...

Research with bite

Research with bite
2015-07-28
The Tyrannosaurus rex and its fellow theropod dinosaurs that rampage across the screen in movies like Jurassic World were successful predators partly due to a unique, deeply serrated tooth structure that allowed them to easily tear through the flesh and bone of other dinosaurs, says new research from the University of Toronto Mississauga (UTM). The research, published in the journal Scientific Reports, was conducted by Kirstin Brink, a post-doctoral researcher in the Department of Biology at UTM; Professor Robert Reisz of the Department of Biology and the UTM vice-principal ...

Brain disease scenarios revised by step-by-step imaging of toxic aggregation

2015-07-28
Diseases like Alzheimer's are caused when proteins aggregate and clump together. In a world first, EPFL scientists have successfully distinguished between the disease-causing aggregation forms of proteins. The finding can help change pharmaceutical treatment of neurodegenerative diseases. Because of our increasing lifespan, diseases like Parkinson's, Huntington's and Alzheimer's are on the rise. They are caused when certain proteins misfold and aggregate together, forming clumps that damage neurons in the brain and spinal cord. This aggregation evolves progressively through ...

Pitt study: Ancient proteins involved in DNA repair could shed light on tumor development

2015-07-28
PITTSBURGH, July 28, 2015 - By studying the yeast used in beer- and bread-making, researchers at the University of Pittsburgh School of Medicine have uncovered the mechanism by which ancient proteins repair DNA damage and how their dysfunction could lead to the development of tumors. The findings, published online today in Nature Communications, could lead to new ways to tailor cancer therapies. In humans, protein mutations called RAD51 paralogues have been associated with breast and ovarian tumors, said senior investigator Kara Bernstein, Ph.D., assistant professor of ...

Plant light sensors came from ancient algae

2015-07-28
DURHAM, N.C. -- The light-sensing molecules that tell plants whether to germinate, when to flower and which direction to grow were inherited millions of years ago from ancient algae, finds a new study from Duke University. The findings are some of the strongest evidence yet refuting the prevailing idea that the ancestors of early plants got the red light sensors that helped them move from water to land by engulfing light-sensing bacteria, the researchers say. The results appear online in Nature Communications. "Much like we see the world through our eyes, plants 'see' ...

Specific cardiovascular risk factors may predict Alzheimer's disease

2015-07-28
OAK BROOK, Ill. - Specific cardiovascular risk factors, such as alcohol consumption, smoking, obesity and diabetes, are associated with smaller regional brain volumes that may be early indicators of Alzheimer's disease and dementia according to a study published online in the journal Radiology. "We already know that vascular risk factors damage the brain and can result in cognitive impairment," said Kevin S. King, M.D., assistant professor of radiology at the Keck School of Medicine of the University of Southern California in Los Angeles. "But our findings give us a more ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Major European mouse study reveals the role of genes in disease